Key Points
- Interpret CSF as a panel tied to a clinical syndrome, not as isolated protein, glucose, or cell-count abnormalities.
- Pair CSF glucose with serum glucose; the ratio can be more informative than the absolute CSF value.
- Neutrophilic, lymphocytic, and mixed pleocytosis patterns overlap and are not perfectly pathogen specific.
- Empiric meningitis or encephalitis therapy should not be delayed when the clinical syndrome is high risk.
- Prior antibiotics can reduce CSF culture yield.
- Multiplex PCR panels are rapid but do not replace culture or clinical judgment.
- Traumatic tap correction formulas are approximations and should not falsely reassure against infection or hemorrhage.
- Sequential tube clearing does not reliably exclude subarachnoid hemorrhage.
- HSV PCR can be falsely negative very early; repeat testing may be needed when suspicion remains high.
- Opening pressure is meaningful only when measured with proper technique and interpreted in context.
Algorithm
- Clarify the indication for lumbar puncture and assess whether neuroimaging is required before LP based on clinical risk.
- Measure opening pressure correctly when it is clinically relevant.
- Send cell count with differential, protein, glucose, and a paired serum glucose for most inflammatory/infectious evaluations.
- Add Gram stain and culture when bacterial infection is possible.
- Add targeted PCR, antigen, fungal, mycobacterial, cytology, flow cytometry, or immune studies based on the differential.
- Start empiric therapy immediately when bacterial meningitis or HSV encephalitis is strongly suspected and diagnostic delay is possible.
- Interpret RBCs in light of procedure difficulty, imaging, timing, and SAH probability rather than tube clearing alone.
- If malignant or inflammatory disease remains suspected despite nondiagnostic CSF, consider repeat sampling or alternate testing.
- Reassess results with the patient's immune status, prior antibiotics, and clinical trajectory.
Clinical Synopsis & Reasoning
Lumbar puncture answers different questions in meningitis, encephalitis, inflammatory disease, malignancy, and suspected subarachnoid hemorrhage, so CSF should be interpreted against the pretest diagnosis. Opening pressure is measured in the lateral decubitus position when intracranial pressure information matters and the procedure is safe. Cell count and differential distinguish pleocytosis from a normal sample, but differential patterns overlap. Bacterial meningitis classically produces neutrophilic pleocytosis, high protein, and low CSF glucose relative to serum; viral meningitis often produces lymphocytic pleocytosis with relatively preserved glucose; tuberculosis and fungal meningitis often produce lymphocyte-predominant inflammation with low glucose and high protein. Early viral disease can be neutrophilic, and partially treated bacterial meningitis can be atypical.
Glucose should be paired with a serum measurement because absolute CSF glucose reflects systemic glucose. A low CSF-to-serum glucose ratio supports bacterial, fungal, tuberculous, or malignant processes. Protein is nonspecific and rises with inflammation, blood contamination, impaired CSF flow, demyelination, and other conditions. Very high protein can occur with bacterial infection or spinal block. Oligoclonal bands and IgG index are used in demyelinating and inflammatory evaluation, but must be interpreted with serum studies and clinical imaging.
A traumatic lumbar puncture introduces erythrocytes and can also increase measured white cells and protein. Formulas that subtract a fixed number of WBCs per RBC are approximations and should not overrule the clinical picture. Declining RBC counts across sequential tubes do not reliably exclude subarachnoid hemorrhage. Xanthochromia reflects hemoglobin breakdown and its detection depends on timing and laboratory method. In contemporary SAH evaluation, the decision to perform LP after imaging depends on timing, CT quality, and residual clinical probability.
Microbiology should be targeted. Gram stain and culture remain important in suspected bacterial meningitis, but prior antibiotics reduce culture yield. Multiplex PCR panels can rapidly detect selected pathogens but do not detect every organism and can produce false-positive or false-negative results. HSV PCR is central to suspected herpes encephalitis; very early testing can be negative, and repeat testing is appropriate when clinical suspicion remains high. Immunocompromised patients require a broader pathogen differential and often additional antigen, PCR, fungal, or mycobacterial testing.
Treatment Strategy & Disposition
Suspected bacterial meningitis is a treatment emergency. Blood cultures and CSF should be obtained promptly when safe, but empiric antibiotics and indicated dexamethasone should not be delayed for imaging or lumbar puncture when delay is expected. Antimicrobial choice depends on age, immune status, exposure, and local resistance. Suspected HSV encephalitis warrants empiric IV acyclovir while diagnostic testing proceeds because delay can worsen neurologic outcome.
Abnormal opening pressure can change management. Markedly elevated pressure with cryptococcal meningitis often requires serial therapeutic lumbar punctures or other pressure management in addition to antifungal therapy. Idiopathic intracranial hypertension requires a different clinical and imaging framework and cannot be diagnosed from a single high opening pressure obtained in poor position or under conditions that artifactually elevate pressure.
Malignant cells on cytology or flow cytometry can diagnose leptomeningeal disease, but sensitivity of a single specimen is limited. Adequate CSF volume, prompt processing, and repeat sampling may improve yield. In inflammatory neurologic disease, CSF is supportive rather than standalone; MRI, serum antibodies, infectious exclusion, and clinical course matter. If a patient develops severe post-dural-puncture headache, treat with conservative measures and consider epidural blood patch when persistent and clinically appropriate.
Epidemiology / Risk Factors
- Viral meningitis is more common than bacterial meningitis in many populations, but bacterial disease carries much greater immediate mortality.
- Pathogen prevalence varies by age, vaccination status, geography, immune status, and season.
- Cryptococcal meningitis is concentrated among immunocompromised patients but can occur outside advanced HIV.
- Leptomeningeal malignancy occurs most often with selected solid tumors and hematologic cancers.
- Traumatic lumbar puncture is common enough that blood-contaminated CSF is a routine interpretation problem.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| Opening pressure | Assesses CSF pressure when relevant | Elevated in selected infections, venous disease, IIH, mass-effect states | Technique and patient position are critical |
| Cell count and differential | Detects inflammation and predominant cell type | Neutrophilic, lymphocytic, eosinophilic, or mixed pleocytosis | Patterns overlap by disease and timing |
| CSF protein | Reflects blood-CSF barrier disruption and other processes | Elevated in infection, inflammation, block, blood contamination | Nonspecific |
| CSF and serum glucose | Assesses glucose consumption/transport | Low ratio in bacterial, TB, fungal, and some malignant meningitides | Pair with serum glucose |
| Gram stain and culture | Detects bacterial pathogens | Organism identification and susceptibility | Culture yield falls after antibiotics |
| PCR/multiplex molecular testing | Rapid pathogen detection | Positive pathogen-specific nucleic acid | Panel coverage and false results require context |
| Oligoclonal bands/IgG index | Supports intrathecal immunoglobulin synthesis | CSF-restricted bands or elevated index | Used with MRI and clinical criteria |
| Cytology/flow cytometry | Detects malignant cells/clonal populations | Malignant cytology or clonal immunophenotype | Repeat/adequate-volume sampling may improve sensitivity |
Typical Patterns
| Condition | Cells and chemistries |
|---|---|
| Acute bacterial meningitis | Usually neutrophilic pleocytosis, high protein, low CSF glucose/ratio; patterns can be atypical after treatment or immunosuppression |
| Viral meningitis | Usually lymphocytic pleocytosis, modest protein elevation, relatively preserved glucose; early neutrophils can occur |
| Tuberculous or fungal meningitis | Often lymphocytic pleocytosis, high protein, low glucose, and elevated opening pressure depending on pathogen |
| Subarachnoid hemorrhage | RBCs and xanthochromia depending on timing and method; interpret with CT timing and clinical probability |
| Multiple sclerosis | CSF-restricted oligoclonal bands and/or elevated IgG index can support diagnosis in the correct clinical/MRI setting |
| Guillain-Barré syndrome | Albuminocytologic dissociation can emerge over time; normal early protein does not exclude disease |
| Leptomeningeal malignancy | Elevated protein, low glucose, variable pleocytosis; diagnosis relies on cytology/flow and clinical imaging |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Empiric IV antibiotics | Rapid bactericidal therapy | Minutes to hours | Suspected bacterial meningitis | Selection depends on age, immune status, allergy and local resistance |
| Dexamethasone | Anti-inflammatory corticosteroid | Hours | Given before or with first antibiotics in selected suspected bacterial meningitis, especially pneumococcal disease | Benefit depends on setting/pathogen; not a substitute for antibiotics |
| Acyclovir | Inhibits viral DNA polymerase after activation | Hours | Empiric treatment for suspected HSV encephalitis | Renal dose adjustment, hydration and nephrotoxicity monitoring |
| Amphotericin-based antifungal therapy | Disrupts fungal cell membrane | Days | Induction therapy in selected fungal meningitis such as cryptococcosis | Nephrotoxicity/electrolyte toxicity; regimen depends on guideline and host |
| Analgesics/caffeine or epidural blood patch | Symptom control/seals dural leak | Hours | Post-dural-puncture headache | Blood patch is procedural and used when symptoms persist or are severe |
Prognosis / Complications
- Prognosis varies from self-limited viral meningitis to rapidly fatal untreated bacterial meningitis or encephalitis.
- Early effective antimicrobial therapy improves outcomes in bacterial meningitis and HSV encephalitis.
- Neurologic sequelae can include hearing loss, cognitive impairment, seizures, stroke, and focal deficits.
- Cryptococcal outcomes depend strongly on antifungal therapy and intracranial-pressure control.
- Leptomeningeal malignancy generally indicates advanced disease but prognosis varies with tumor type and treatment responsiveness.
Patient Education / Counseling
- Explain why lumbar puncture is being performed and which diagnoses it can and cannot establish.
- Discuss common post-procedure headache and when to seek care for severe persistent symptoms, fever, new weakness, or altered consciousness.
- Patients treated empirically should understand that therapy may begin before CSF results because delay can be dangerous.
- When results are indeterminate, explain that repeat testing can be medically necessary rather than evidence that the first procedure was done incorrectly.
- Immunocompromised patients should receive specific counseling about opportunistic infection risk and follow-up.
Notes
Lumbar puncture safety depends on recognizing patients at risk for mass effect, obstructive hydrocephalus, severe coagulopathy, or local infection at the puncture site. Routine head CT before every LP is not necessary and can delay treatment; imaging decisions should follow clinical risk factors.
CSF interpretation changes over time. Cell differential can evolve, antimicrobial therapy can sterilize culture, xanthochromia develops after blood has been present in CSF, and antibody indices may reflect a chronic process rather than acute symptoms. Time from symptom onset and time from treatment initiation should therefore be documented.
When a multiplex panel is positive for an unexpected organism, reconcile it with CSF cells, host factors, exposure, and confirmatory testing before committing to prolonged therapy. Molecular assays are powerful but do not eliminate pretest probability or laboratory stewardship.
References
- WHO Guidelines on Meningitis Diagnosis, Treatment and Care 2025 — Link
- Infectious Diseases Society of America Clinical Practice Guidelines — Link
Practice the decision pattern next.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback